2015
DOI: 10.17795/semj26242
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Obesity Drug Orlistat (Xenical) Is a Novel Antitumor Medication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 21 publications
2
7
0
Order By: Relevance
“…According to a study by Greaves (2011) (30), micro vesicular fatty change is more likely a sign of toxicity while macro vesicular fatty change is related with metabolic abnormalities and is typically easily reversible. These findings are consistent with (31) which demonstrated that orlistat increased cell proliferation.…”
Section: The Results and Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…According to a study by Greaves (2011) (30), micro vesicular fatty change is more likely a sign of toxicity while macro vesicular fatty change is related with metabolic abnormalities and is typically easily reversible. These findings are consistent with (31) which demonstrated that orlistat increased cell proliferation.…”
Section: The Results and Discussionsupporting
confidence: 91%
“…These oxidizing substances deteriorate lumen membranes and speed up cell death. Leila and others, 2015 (31).…”
Section: Figure (3-6) Section Of Liver In Rabbits Treated With Xenica...mentioning
confidence: 97%
“…Aside from FASN inhibition, orlistat was also postulated to exert its antiproliferative effect via other mechanisms, such as induction of apoptosis, or reduction of proliferation rate due to direct toxicity and stimulation of intracellular accumulation of reactive oxygen species (34). However, our findings suggest that in the case of pancreatic cancer cells, reduced proliferation is a consequence of orlistat-mediated inhibition of FASN.…”
Section: Discussionmentioning
confidence: 60%
“…HFD was widely employed to explore the pathophysiology of obesity and its related complications in view of its characteristics that closely mimic human obesity. Scientific evidence has demonstrated that orlistat exhibits a wide range of pharmacological activities, for example, anti-obesity [ 9 ], anti-inflammatory [ 15 ], and anti-tumour [ 16 ] activities, as well as improved oxidative stress status in the brain, renal, testis, and liver organs [ 17 , 18 , 19 ]. In our earlier studies, orlistat that was given to HFD-fed rats for 6 and 12 weeks, had shown to significantly improve the oxidant–antioxidant status in the heart and aorta tissues [ 11 , 13 ].…”
Section: Discussionmentioning
confidence: 99%